FDA clears Edwards Lifesciences’ expandable pediatric pulmonary valve
AI Summary- Edwards Lifesciences received FDA clearance for its AUTUS Size-Adjustable Valve.
- 62 pediatric patients achieved a 100% success rate with no deaths or intervention-requiring blood clots.
- Edwards plans 10 years of follow-up after one-year assessments showed consistent valve performance.